Arzneimittel enthaltend wenigstens einen Teil des UL84-Proteins des Cytomegalovirus, Verwendung von Polypeptiden entsprechend der Aminosäuresequenz des UL84-Proteins und Verfahren zur Einführung von UL84 in Zielzellen

摘要

The human cytomegalovirus is an important disease producer in various problem groups like immuno-suppressed patients, new-born children or transplant patients. The publication concerns the use of polypeptides corresponding at least partly to the UL84 sequence as medicaments and the use of the corresponding gene in suitable transfer vectors.